Lorena Infante Lara

As a researcher affiliated with Vanderbilt University, you should never pay for a scholarly journal article. Vanderbilt’s system of libraries offers several tools that can be helpful when accessing library resources on the open web. Read More

A recent review from the pharmacology lab of Valentina Cigliola explores the remarkable regenerative capabilities of zebrafish and neonatal mice and how insights into these mechanisms could pave the way for innovative and regenerative therapies in humans suffering from spinal cord injuries or neurodegenerative diseases. Read More

Driven by personal loss, a graduate student and his mentors unveil the mysteries of CFTR mutations, seeking to unlock new treatments for cystic fibrosis patients who currently resist available drugs. Read More

For the nearly 30 percent of major depressive disorder patients who are resistant to treatment, ketamine provides some amount of normalcy, but it requires frequent treatment and can have side effects. Vanderbilt researchers now show in proof-of-concept experiments that it may be possible to extend ketamine’s antidepressant effect from about a week to up to two months. Read More

A recent paper from the lab of Emily Hodges looks at how two types of epigenetic changes act together but on different time scales to affect gene expression during cell differentiation. Read More

In a new study published in Nature Communications, the Doug Kojetin and Zhongyue Yang labs use peroxisome proliferator-activated receptor gamma—more commonly known as PPAR—as a model system to understand the functional shifts of nuclear receptor LBDs. Read More

Vanderbilt researchers have developed a nanoparticle complex that can both visualize and attack cancer cells by targeting the tumor microenvironment. Read More

In a recent study, Vanderbilt researchers address a significant gap in our understanding of how noncoding regions of the genome regulate important biological processes, such as X-chromosome inactivation. They use an innovative, single-cell approach to uncover new mechanistic insights into how specific long noncoding RNAs control critical gene regulation events. Read More

Vanderbilt researchers developed a deep-learning tool, RNAmigos2, that accelerates the discovery of RNA-targeting small-molecule drugs by 10,000 times compared to traditional methods, unlocking a promising new frontier in medicine. Read More

Researchers from the Vanderbilt University Medical Center and Vanderbilt University have figured out how two bacterial elements present in only some Helicobacter pylori strains lead to molecular changes in host tissues that favor the development of gastric cancer. Read More